Take (NSE:TAKE) Inventories, Work In Process: ₹0.0 Mil (As of Mar. 2026)


NSE:TAKE Take Ltd NSE:TAKE
40 GF Score
Price ₹23.97
GF Value ₹0.01
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Take Inventories, Work In Process?

Take NSE:TAKE +4.99% 40 Inventories, Work In Process is ₹0.0 Mil as of Mar. 2026. GuruFocus rates NSE:TAKE with a GF Score™ of 40/100 and a GF Value™ of ₹0.01 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Take's work in process for the quarter that ended in Mar. 2026 was ₹0.0 Mil.

Take Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Take's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Take Inventories, Work In Process Chart

Take Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Take Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:TAKE
40GF Score
Take Ltd NSE:TAKE
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Take Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of ₹0.0 Mil mean?
Take (NSE:TAKE) has a Inventories, Work In Process of ₹0.0 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Take and its competitors.
Is Take's Inventories, Work In Process too high?
Take's current Inventories, Work In Process is ₹0.0 Mil. Overall, Take has a GF Score™ of 40/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Take's Inventories, Work In Process compare to VRTX and REGN?
Take's Inventories, Work In Process of ₹0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Healthcare Providers & Services company?
A good Inventories, Work In Process depends on the Healthcare Providers & Services industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Take and its competitors. Take's current Inventories, Work In Process is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Take stock overvalued right now?
Based on GuruFocus' analysis, Take (NSE:TAKE) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.01, compared to a current price of ₹23.97 — trading 239600% above its estimated fair value. The current Inventories, Work In Process is ₹0.0 Mil. Take's overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Take (NSE:TAKE), the current Inventories, Work In Process is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Take (NSE:TAKE) Overvalued in 2026?

Based on GuruFocus' analysis, Take stock appears to be overvalued. The current stock price of ₹23.97 is trading 239600% above its estimated GF Value™ of ₹0.01. GuruFocus considers Take to be Significantly Overvalued.

Key valuation signals for NSE:TAKE:

  • Inventories, Work In Process: ₹0.0 Mil
  • GF Value™: ₹0.01 vs. price of ₹23.97 (239600% above fair value)
  • GF Score™: 40/100 with 3 warning signs

No single metric tells the full story. See the NSE:TAKE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Take Business Description

Other Exchanges 532890:India
Address No.56, Old No. 116, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Take Solutions Ltd is a technology solutions provider specializing in Life Sciences and Supply Chain Management services. The company offers integrated services including clinical research, generics support, regulatory affairs, pharmacovigilance, and data sciences. It supports pharmaceutical, biotech, and medical device companies to various countries with technology-backed solutions that enhance drug development and regulatory compliance. Revenue is driven by its broad portfolio of IT-enabled services focused on the life sciences industry and supply chain management, catering to a client base of innovators, generics manufacturers, and biotech firms.
40GF Score

Get the complete analysis for NSE:TAKE

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.97
Price
₹0.01
GF Value